Astrantus’s Merck MRK Stock Holding History

Astrantus’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$484K	Sell	5,900 -6,488	-52%	-$512K	0.81%	3
2021 Q4	$949K	Buy	+12,388	New	+$987K	0.71%	49

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Astrantus's MRK Position: Q1 2022 in Review

Astrantus reduced its Merck (MRK) stake by 52% in Q1 2022, selling an estimated $512K and leaving 5,900 shares worth $484K. The position accounts for 0.81% of the portfolio, ranked #3.

Astrantus first reported a position in MRK in Q4 2021 and has held it in 2 quarters since. The position peaked at $949K in Q4 2021. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

Astrantus held 5,900 shares of Merck worth $484K as of Q1 2022.
Astrantus sold 6,488 Merck shares in Q1 2022, an estimated $512K.
Merck made up 0.81% of Astrantus's portfolio in Q1 2022, its #3 holding.
Astrantus first reported a position in Merck in Q4 2021 and has held it in 2 quarters since.
Astrantus's Merck position peaked at $949K in Q4 2021.
2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.